Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis

Halina Offner, Margarita Vainiene, Bozena Celnik, Andrew D. Weinberg, Abigail Buenafe, Arthur Vandenbark

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

TCR peptides, namely Vβ8.2-39-59 or the minimal idiotope, Vβ8-44-54, can treat experimental autoimmune encephalomyelitis (EAE) in Lewis rats, presumably by activating naturally induced TCR peptide-specific T cells that arise in response to the focused appearance of Vβ8.2+ encephalitogenic T cells. The purpose of the present study was to evaluate the mechanisms by which TCR peptides inhibit EAE. We found that treatment of EAE with the Vβ8.2-39-59 peptide did not induce any evidence of DNA fragmentation (apoptosis) in spinal cord cells isolated from clinically well rats, implicating a regulatory rather than a deletional mechanism. TCR peptide- specific T cell lines failed to inhibit EAE induced by already activated BP- specific T cells when the two T cell specificities were co-injected. However, coculturing the encephalitogenic T cells in the presence of the regulatory T cells during the activation step before transfer almost completely inhibited the induction of EAE. Inhibition could be induced by direct contact between the two cell types or by soluble factors produced in a transwell system, but was greatly enhanced when soluble Vβ8.2-39-59 peptide was used to optimally activate the regulatory T cells. The inhibition was regulatory cell dose dependent, and was reflected in vitro by reduced proliferation response and mRNA production for IL-3, and to a lesser extent, IFN-γ and IL-2. These results indicate that regulation induced by TCR peptides involves cell-cell interactions that lead to the production and release of soluble factors that locally inhibit the activation of encephalitogenic T cells expressing MHC- bound idiotopes of the target Vβ-chain, and possibly 'bystander' specificities expressing different Vβ-chains.

Original languageEnglish (US)
Pages (from-to)4988-4996
Number of pages9
JournalJournal of Immunology
Volume153
Issue number11
StatePublished - Dec 1 1994

Fingerprint

Peptide T
Autoimmune Experimental Encephalomyelitis
Interleukin-3
Coculture Techniques
Cell Proliferation
T-Lymphocytes
Messenger RNA
Peptides
Proteins
Regulatory T-Lymphocytes
T-Cell Antigen Receptor Specificity
DNA Fragmentation
Cell Communication
Interleukin-2
Spinal Cord
Apoptosis
Cell Line

ASJC Scopus subject areas

  • Immunology

Cite this

Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis. / Offner, Halina; Vainiene, Margarita; Celnik, Bozena; Weinberg, Andrew D.; Buenafe, Abigail; Vandenbark, Arthur.

In: Journal of Immunology, Vol. 153, No. 11, 01.12.1994, p. 4988-4996.

Research output: Contribution to journalArticle

@article{13e04d51199c4d8aa32115e6fe17cd2c,
title = "Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis",
abstract = "TCR peptides, namely Vβ8.2-39-59 or the minimal idiotope, Vβ8-44-54, can treat experimental autoimmune encephalomyelitis (EAE) in Lewis rats, presumably by activating naturally induced TCR peptide-specific T cells that arise in response to the focused appearance of Vβ8.2+ encephalitogenic T cells. The purpose of the present study was to evaluate the mechanisms by which TCR peptides inhibit EAE. We found that treatment of EAE with the Vβ8.2-39-59 peptide did not induce any evidence of DNA fragmentation (apoptosis) in spinal cord cells isolated from clinically well rats, implicating a regulatory rather than a deletional mechanism. TCR peptide- specific T cell lines failed to inhibit EAE induced by already activated BP- specific T cells when the two T cell specificities were co-injected. However, coculturing the encephalitogenic T cells in the presence of the regulatory T cells during the activation step before transfer almost completely inhibited the induction of EAE. Inhibition could be induced by direct contact between the two cell types or by soluble factors produced in a transwell system, but was greatly enhanced when soluble Vβ8.2-39-59 peptide was used to optimally activate the regulatory T cells. The inhibition was regulatory cell dose dependent, and was reflected in vitro by reduced proliferation response and mRNA production for IL-3, and to a lesser extent, IFN-γ and IL-2. These results indicate that regulation induced by TCR peptides involves cell-cell interactions that lead to the production and release of soluble factors that locally inhibit the activation of encephalitogenic T cells expressing MHC- bound idiotopes of the target Vβ-chain, and possibly 'bystander' specificities expressing different Vβ-chains.",
author = "Halina Offner and Margarita Vainiene and Bozena Celnik and Weinberg, {Andrew D.} and Abigail Buenafe and Arthur Vandenbark",
year = "1994",
month = "12",
day = "1",
language = "English (US)",
volume = "153",
pages = "4988--4996",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Coculture of TCR peptide-specific T cells with basic protein-specific T cells inhibits proliferation, IL-3 mRNA, and transfer of experimental autoimmune encephalomyelitis

AU - Offner, Halina

AU - Vainiene, Margarita

AU - Celnik, Bozena

AU - Weinberg, Andrew D.

AU - Buenafe, Abigail

AU - Vandenbark, Arthur

PY - 1994/12/1

Y1 - 1994/12/1

N2 - TCR peptides, namely Vβ8.2-39-59 or the minimal idiotope, Vβ8-44-54, can treat experimental autoimmune encephalomyelitis (EAE) in Lewis rats, presumably by activating naturally induced TCR peptide-specific T cells that arise in response to the focused appearance of Vβ8.2+ encephalitogenic T cells. The purpose of the present study was to evaluate the mechanisms by which TCR peptides inhibit EAE. We found that treatment of EAE with the Vβ8.2-39-59 peptide did not induce any evidence of DNA fragmentation (apoptosis) in spinal cord cells isolated from clinically well rats, implicating a regulatory rather than a deletional mechanism. TCR peptide- specific T cell lines failed to inhibit EAE induced by already activated BP- specific T cells when the two T cell specificities were co-injected. However, coculturing the encephalitogenic T cells in the presence of the regulatory T cells during the activation step before transfer almost completely inhibited the induction of EAE. Inhibition could be induced by direct contact between the two cell types or by soluble factors produced in a transwell system, but was greatly enhanced when soluble Vβ8.2-39-59 peptide was used to optimally activate the regulatory T cells. The inhibition was regulatory cell dose dependent, and was reflected in vitro by reduced proliferation response and mRNA production for IL-3, and to a lesser extent, IFN-γ and IL-2. These results indicate that regulation induced by TCR peptides involves cell-cell interactions that lead to the production and release of soluble factors that locally inhibit the activation of encephalitogenic T cells expressing MHC- bound idiotopes of the target Vβ-chain, and possibly 'bystander' specificities expressing different Vβ-chains.

AB - TCR peptides, namely Vβ8.2-39-59 or the minimal idiotope, Vβ8-44-54, can treat experimental autoimmune encephalomyelitis (EAE) in Lewis rats, presumably by activating naturally induced TCR peptide-specific T cells that arise in response to the focused appearance of Vβ8.2+ encephalitogenic T cells. The purpose of the present study was to evaluate the mechanisms by which TCR peptides inhibit EAE. We found that treatment of EAE with the Vβ8.2-39-59 peptide did not induce any evidence of DNA fragmentation (apoptosis) in spinal cord cells isolated from clinically well rats, implicating a regulatory rather than a deletional mechanism. TCR peptide- specific T cell lines failed to inhibit EAE induced by already activated BP- specific T cells when the two T cell specificities were co-injected. However, coculturing the encephalitogenic T cells in the presence of the regulatory T cells during the activation step before transfer almost completely inhibited the induction of EAE. Inhibition could be induced by direct contact between the two cell types or by soluble factors produced in a transwell system, but was greatly enhanced when soluble Vβ8.2-39-59 peptide was used to optimally activate the regulatory T cells. The inhibition was regulatory cell dose dependent, and was reflected in vitro by reduced proliferation response and mRNA production for IL-3, and to a lesser extent, IFN-γ and IL-2. These results indicate that regulation induced by TCR peptides involves cell-cell interactions that lead to the production and release of soluble factors that locally inhibit the activation of encephalitogenic T cells expressing MHC- bound idiotopes of the target Vβ-chain, and possibly 'bystander' specificities expressing different Vβ-chains.

UR - http://www.scopus.com/inward/record.url?scp=0027943571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027943571&partnerID=8YFLogxK

M3 - Article

VL - 153

SP - 4988

EP - 4996

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -